NT2, The answer is very simple and you may have an
Post# of 148110
(Total Views: 646)
Posted On: 05/09/2020 3:31:37 PM
Re: Nt2innvovate #33163
NT2, The answer is very simple and you may have answered your question already. The problem with HCQ is $4. Gilead wont sell its Remdesivir for $4. Covid-19 to BP is like the Goose that will laid a golden egg. It is the very same reason Leronlimab is not getting the recognition as fast as we hope. But our day will come!!
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼